Unii-o0p4I5851i
|
|
Unii-o0p4I5851i 속성
- 녹는점
- >250°C (dec.)
- 저장 조건
- Refrigerator
- 용해도
- 클로로포름(아주 약간, 초음파 처리), 메탄올(약간, 가열)에 용해됨
- 물리적 상태
- 고체
- 물리적 상태
- 단단한 모양
- 색상
- 흰색에서 황백색까지
- CAS 데이터베이스
- 139563-29-4
안전
Unii-o0p4I5851i C화학적 특성, 용도, 생산
Clinical Use
Lurasidone hydrochloride is an antipsychotic developed by the Japanese firm Dainippon Sumitomo and approved by the U.S. FDA for the treatment of schizophrenia. The compound exhibits significant antagonist effects at the D2, 5-HT2A, and 5-HT7 receptors which are linked to learning and cognition. In contrast to available antipsychotics, lurasidone lacks anticholinergic side effects, giving it an improved safety profile against existing treatments.139 The drug is manufactured under the trade name Latuda and possesses a linear molecular topology which can be subdivided into three regions: a piperazine benzothiazole, a [2.2.1]-bicycloheptane fused succinimide, and a trans-1,2 disubstituted cyclohexane.Synthesis
The large scale preparation of lurasidone involves an interesting ring-opening alkylation reaction of a spirocyclic tetralkyl ammonium salt to produce the 1,2-trans-substituted cyclohexane subunit. The synthesis commenced with the bismesylation of commercially available diol 177, which proceeded in high yield to give disulfone 178. This bis-electrophile underwent dialkylation with commercially available piperazine 179 under basic conditions, giving rise to ammonium species 180, isolated in 80% yield as the mono-mesylate salt. This compound was immediately subjected to alkylative conditions in the presence of commercially available succinimide 181 to provide lurasidone in 94% yield from 180, and lurasidone hydrochloride (XVI) was achieved by subsequent salt formation procedure.Unii-o0p4I5851i 준비 용품 및 원자재
원자재
준비 용품
Unii-o0p4I5851i 공급 업체
글로벌( 45)공급 업체
공급자 | 전화 | 이메일 | 국가 | 제품 수 | 이점 |
---|---|---|---|---|---|
Sinoway Industrial co., ltd. | 0592-5800732; +8613806035118 |
xie@china-sinoway.com | China | 992 | 58 |
sgtlifesciences pvt ltd | +8617013299288 |
dj@sgtlifesciences.com | China | 12382 | 58 |
Shandong Risen-Sun Pharmaceutical Co., Ltd | +86-15552509998 +86-15621883869 |
liutf@jewim.com.cn | China | 251 | 58 |
Suzhou ARTK Medchem Co., Ltd. | +86-512-68323967 +86-18015559028 |
sales1@artkmedchem.com | China | 39009 | 58 |
Shenzhen SUNGENING Bio-Medical Co., Ltd. | 0755-28967200 13631290199 |
wxf@sungening.com | China | 9507 | 60 |
Conier Chem & Pharma Limited | 13368167990 |
sales@conier.com | China | 2809 | 58 |
Shenzhen Polymeri Biochemical Technology Co., Ltd. | +86-400-002-6226 13028896684 |
sales@rrkchem.com | China | 55954 | 58 |
Cato Research Chemicals Inc. | 020-81215950 4000-868-328 |
customer@uwalab.com | United States | 10413 | 58 |
Shaanxi Dideu Medichem Co. Ltd | 029-61856359 18690052321 |
1027@dideu.com | China | 10011 | 58 |